Wave Life Sciences (WVE) Non-Current Assets (2014 - 2026)

Wave Life Sciences' Non-Current Assets history runs 13 years deep, the most recent figure standing at $22.3 million for Q1 2026.

• Quarterly Non-Current Assets fell 26.66% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 million (down 26.66% YoY) and the FY2025 annual result came in at $23.7 million, down 25.55% from the prior year.
• Non-Current Assets was $22.3 million for Q1 2026 at Wave Life Sciences, down from $23.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $53.2 million in Q2 2022 and bottomed at $22.3 million in Q1 2026.
• A 5-year average of $37.6 million and a median of $38.5 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets increased 17.76% — and 2026, when it dropped 26.66%.
• Wave Life Sciences' Non-Current Assets stood at $47.8 million in 2022, then retreated by 17.29% to $39.6 million in 2023, then fell by 19.62% to $31.8 million in 2024, then decreased by 25.55% to $23.7 million in 2025, then dropped by 5.97% to $22.3 million in 2026.
• Business Quant data shows WVE's Non-Current Assets at $22.3 million in Q1 2026, $23.7 million in Q4 2025, and $25.9 million in Q3 2025.